Procter & Gamble reported 2% organic sales growth for the fourth quarter of 2025.
Sales volume remained flat during the period. Pricing gains contributed 1% to organic sales growth. Product mix added another 1% to the quarterly results. The full-year core gross margin declined by 40 basis points due to input costs.
Full-year earnings per share reached $6.83. This figure represents a 4% increase over the previous year. JPMorgan trimmed its price target for the company to $162. Barclays cut its price target to $146, citing costs and shifting consumer behavior.
P&G expects fiscal 2026 organic sales growth to range from 0% to 4%. The company forecasts fiscal 2026 core earnings between $6.83 and $7.09 per share.